ereprof. dr. Genevieve Laureys
Show
Sort by
-
Deletion of chromosome 11q is the most frequent deletion detected by CGH in metastatic neuroblastoma lacking MYCN amplification
-
Imaging with Technetium-99m sestamibi does not predict drug resistance or outcome in childhood neuroblastoma
-
Treatment of childhood T-cell lymphoblastic non-Hodgkin lymphoma according to the strategy for acute lymphoblastic leukemia: Long-term results of the EORTC 58881 trial
-
Combined evaluation of P-glycoprotein expression and activity contributes to the identification of children at risk for leukaemic relapse
-
Combined M-FISH and CGH analysis allows comprehensive description of genetic alterations in neuroblastoma cell lines.
-
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11Q deletion in tumors lacking MYCN amplification.
-
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there?
-
Reversion of Autoimmune Lymphoproliferative Syndrome with an anti malaria drug: Clinical and molecular observations
-
Chromosome 2 short arm translocations revealed by M-FISH analysis of neuroblastoma cell lines.
-
Long-term results of three randomized trials (58831,58832,58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report.